Administration of Direct Oral Anticoagulant Immediately after Unfractionated Heparin Bolus for the Treatment of Intermediate-High-Risk Pulmonary Thromboembolism.

Hara, Nobuhiro; Watanabe, Keita; Miyazaki, Ryoichi; Nakamura, Tomofumi; Lee, Tetsumin; Nagata, Yasutoshi; Nozato, Toshihiro; Miyamoto, Takamichi; Obayashi, Toru; Ashikaga, Takashi

Hara, Nobuhiro; Watanabe, Keita; Miyazaki, Ryoichi; Nakamura, Tomofumi; Lee, Tetsumin; Nagata, Yasutoshi; Nozato, Toshihiro; Miyamoto, Takamichi; Obayashi, Toru; Ashikaga, Takashi.

Afiliación

Hara N; Department of Cardiology, Japanese Red Cross Musashino Hospital, Tokyo, Japan.
Watanabe K; Department of Cardiology, Japanese Red Cross Musashino Hospital, Tokyo, Japan.
Miyazaki R; Department of Cardiology, Japanese Red Cross Musashino Hospital, Tokyo, Japan.
Nakamura T; Department of Cardiology, Japanese Red Cross Musashino Hospital, Tokyo, Japan.
Lee T; Department of Cardiology, Japanese Red Cross Musashino Hospital, Tokyo, Japan.
Nagata Y; Department of Cardiology, Japanese Red Cross Musashino Hospital, Tokyo, Japan.
Nozato T; Department of Cardiology, Japanese Red Cross Musashino Hospital, Tokyo, Japan.
Miyamoto T; Department of Cardiology, Japanese Red Cross Musashino Hospital, Tokyo, Japan.
Obayashi T; Department of Cardiology, Japanese Red Cross Musashino Hospital, Tokyo, Japan.
Ashikaga T; Department of Clinical Engineering, Gunma Paz College, Takasaki, Gunma, Japan.

Ann Vasc Dis ; 13(4): 370-376, 2020 Dec 25.

Article en En | MEDLINE | ID: mdl-33391553

Palabras clave

anticoagulation; direct oral anticoagulant; intermediatehigh-risk pulmonary embolism; therapy

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Etiology_studies / Risk_factors_studies Idioma: En Revista: Ann Vasc Dis Año: 2020 Tipo del documento: Article País de afiliación: Japón Pais de publicación: Japón

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google